Materias dentro de su búsqueda.
Mostrando 1,043,821 - 1,043,840 Resultados de 1,045,414 Para Buscar '"The Times"', tiempo de consulta: 5.76s Limitar resultados
  1. 1043821
    “…Inhibitors were added at the same time (transcription inhibitor Actinomycin D, 5 μg/ml) or 1 h (FAK inhibitor FAK-14, 10 μM, Src inhibitor PP2, 5 μM, PI3K inhibitor LY294002, 20 μM, NF-kB inhibitors Bay 11-7082 and JSH-23, 10 and 20 μM, respectively, or COX-2 inhibitor NS-398, 20 μM) before RGal treatment. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A179 MECHANISMS OF ACTION INVOLVED IN THE WOUND HEALING EFFECT OF THE DIETARY FIBRE RHAMNOGALACTURONAN
  2. 1043822
    “…For each landmark, we extracted an average of 30 frames for each time of its appearance. All the extracted frames were reviewed and annotated by a team of three clinicians. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A108 AUTOMATED DETECTION OF ILEOCECAL VALVE, APPENDICEAL ORIFICE, AND POLYP DURING COLONOSCOPY USING A DEEP LEARNING MODEL
  3. 1043823
    “…Those who developed CD (n=87) were matched 1:4 by age, sex, follow-up time, and geographic location with control FDRs remaining healthy (n=347). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A238 BILE ACID COMPOSITION AND DIETARY FAT: IMPLICATIONS FOR CROHN’S DISEASE IN A COHORT OF HEALTHY FIRST-DEGREE RELATIVES
  4. 1043824
    “…Both groups had similar time intervals between IBD diagnosis and SL diagnosis (p>0.05), and similar maximal therapeutic maintenance steps (p>0.05), as well as Mayo/SES-CD scores, serum C-reactive protein, hemoglobin, and albumin, and fecal calprotectin values at index and last colonoscopy (p>0.05). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A159 RISK OF TOTAL METACHRONOUS ADVANCED NEOPLASIA IN PATIENTS WITH SERRATED LESIONS AND INFLAMMATORY BOWEL DISEASE
  5. 1043825
    “…Median TABUS bowel wall thickness (BWT) and SUS-CD total scores improved in all bowel segments over time. SUS-CD total scores significantly correlated with SES-CD (baseline, 6-, 12-months), wPCDAI (baseline, 1-, 6-, 12-months), CRP (baseline, 1-, 3-, 6-months), ESR (baseline, 1-, 3-, 6-, 12-months), and FCP (baseline, 1-, 6-, 12-months) (rho ranged 0.302-0.732, p<0.05). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A14 TRANSABDOMINAL BOWEL ULTRASOUND AND CLINICAL OUTCOMES OVER ONE YEAR IN CHILDREN WITH NEWLY DIAGNOSED CROHN’S DISEASE
  6. 1043826
    “…The virtual scale endoscope (VSE) allows projection of a virtual scale onto colorectal polyps allowing real-time size measurements. PURPOSE: We studied the relative accuracy of VSE compared to visual assessment (VA) for the measuring simulated polyps of different size and morphology groups. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A106 COMPARING SIZE MEASUREMENTS OF SIMULATED COLORECTAL POLYPS SIZE AND MORPHOLOGY GROUPS WHEN USING A VIRTUAL SCALE ENDOSCOPE OR VISUAL SIZE ESTIMATION: A BLINDED RANDOMIZED CONTROLLED TRIAL
  7. 1043827
    “…Most students (n=8, 73%) felt the H&P 360 took an appropriate amount of time. CONCLUSIONS: Students who applied the H&P 360 using templated notes in the EHR found it feasible and helpful. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Implementation of a Biopsychosocial History and Physical Exam Template in the Electronic Health Record: Mixed Methods Study
  8. 1043828
    “…Our findings may be attributable to public health measures in place at the time such as movement restrictions and home working that applied to the Virus Watch cohort participants during the study period.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tracking Changes in Mobility Before and After the First SARS-CoV-2 Vaccination Using Global Positioning System Data in England and Wales (Virus Watch): Prospective Observational Community Cohort Study
  9. 1043829
    “…In arm 1, the 24-week clinical benefit rate and median progression-free survival time were 41.3% (90% CI, 29.0%-54.5%) and 5.6 months (95% CI, 3.9-10.0), respectively, and in arm 2 they were 28.9% (90% CI, 18.0%-42.0%) and 5.4 months (95% CI, 3.9-7.8), respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
  10. 1043830
    “…We will assess associations between patient characteristics, treatment choices, and clinical outcomes using path analysis, enabling us to estimate the effect of treatment choices and timing on the clinical outcome. DISCUSSION: The BrainDrugs-Depression study is a real-world deep-phenotyping clinical cohort study of first-episode MDD patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
  11. 1043831
    por Alexeev, M.G., Alexeev, G.D., Amoroso, A., Andrieux, V., Anosov, V., Augsten, K., Augustyniak, W., Azevedo, C.D.R., Badelek, B., Balestra, F., Ball, M., Barth, J., Beck, R., Bedfer, Y., Antequera, J. Berenguer, Bernhard, J., Bodlak, M., Bradamante, F., Bressan, A., Burtsev, V.E., Chang, W.-C., Chatterjee, C., Chiosso, M., Chumakov, A.G., Chung, S.-U., Cicuttin, A., Correia, P.M.M., Crespo, M.L., D'Ago, D., Torre, S. Dalla, Dasgupta, S.S., Dasgupta, S., Denisenko, I., Denisov, O.Yu., Donskov, S.V., Doshita, N., Dreisbach, Ch., Duennweber, W., Dusaev, R.R., Efremov, A., Eremeev, D., Eversheim, P.D., Faccioli, P., Faessler, M., Finger, M., Fischer, H., Floethner, K., Franco, C., Friedrich, J.M., Frolov, V., Ordonez, L.G. Garcia, Gautheron, F., Gavrichtchouk, O.P., Gerassimov, S., Giarra, J., Giordano, D., Gorzellik, M., Grasso, A., Gridin, A., Perdekamp, M. Grosse, Grube, B., Grüner, M., Guskov, A., Haas, F., von Harrach, D., Hoffmann, M., Heitz, R., Horikawa, N., d'Hose, N., Hsieh, C.-Y., Huber, S., Ishimoto, S., Ivanov, A., Iwata, T., Jandek, M., Jary, T., Jary, V., Joosten, R., Kabuss, E., Kaspar, F., Kerbizi, A., Ketzer, B., Khaustov, G.V., Khokhlov, Yu.A., Kisselev, Yu., Klein, F., Koivuniemi, J.H., Kolosov, V.N., Konorov, I., Konstantinov, V.F., Kotzinian, A.M., Kouznetsov, O.M., Koval, A., Kral, Z., Krinner, F., Kulinich, Y., Kunne, F., Kurek, K., Kurjata, R.P., Kveton, A., Lavickova, K., Levorato, S., Lian, Y.-S., Lichtenstadt, J., Lin, P.-J., Longo, R., Lyubovitskij, V.E., Maggiora, A., Magnon, A., Makins, N., Makke, N., Mallot, G.K., Maltsev, A., Mamon, S.A., Marianski, B., Martin, A., Marzec, J., Matousek, J., Matsuda, T., Mattson, G., Metzger, F., Meyer, M., Meyer, W., Mikhailov, Yu.V., Mikhasenko, M., Mitrofanov, E., Miyachi, Y., Moretti, A., Nagaytsev, A., Naim, C., Neyret, D., Novy, J., Nowak, W.-D., Nukazuka, G., Olshevsky, A.G., Ostrick, M., Panzieri, D., Parsamyan, B., Paul, S., Pekeler, H., Peng, J.-C., Pesek, M., Peshekhonov, D.V., Peskova, M., Pierre, N., Platchkov, S., Pochodzalla, J., Polyakov, V.A., Pretz, J., Quaresma, M., Quintans, C., Reicherz, G., Riedl, C., Rudnicki, T., Ryabchikov, D.I., Rymbekova, A., Rychter, A., Samoylenko, V.D., Sandacz, A., Sarkar, S., Savin, I.A., Sbrizzai, G., Schmeing, S., Schmieden, H., Selyunin, A., Sharko, K., Sinha, L., Slunecka, M., Spülbeck, D., Srnka, A., Steffen, D., Stolarski, M., Subrt, O., Sulc, M., Suzuki, H., Tessaro, S., Tessarotto, F., Thiel, A., Tomsa, J., Tosello, F., Townsend, A., Tskhay, V., Triloki, T., Uhl, S., Valinoti, B., Vauth, A., Veit, B.M., Veloso, J., Ventura, B., Vidon, A., Virius, M., Wagner, M., Wallner, S., Zaremba, K., Zavertyaev, M., Zemko, M., Zemlyanichkina, E., Zhao, Y., Ziembicki, M.
    Publicado 2021
    “…We investigate for the first time the amplitude of the <math display="inline"><msup><mi>π</mi><mo>-</mo></msup><msup><mi>π</mi><mo>+</mo></msup></math> subsystem with <math display="inline"><msup><mi>J</mi><mrow><mi>P</mi><mi>C</mi></mrow></msup><mo>=</mo><msup><mn>1</mn><mrow><mo>-</mo><mo>-</mo></mrow></msup></math> in the <math display="inline"><mn>3</mn><mi>π</mi></math> amplitude with <math display="inline"><msup><mi>J</mi><mrow><mi>P</mi><mi>C</mi></mrow></msup><mo>=</mo><msup><mn>1</mn><mrow><mo>-</mo><mo>+</mo></mrow></msup></math> employing the novel freed-isobar analysis scheme. …”
    Enlace del recurso
    Enlace del recurso
    Exotic meson $\pi_1(1600)$ with $J^{PC} = 1^{-+}$ and its decay into $\rho(770)\pi$
  12. 1043832
    “…We calculated the area under the curve (AUC) for gametocyte density over time for comparisons for which data were available. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission
  13. 1043833
    “…We calculated the area under the curve (AUC) for gametocyte density over time for comparisons for which data were available. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission
  14. 1043834
    “…All patients were vaccinated with a median time from vaccine to SARS-CoV-2 infection of 45.5 days (IRQ 19-67.5). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)
  15. 1043835
    “…Univariable relationships between the dichotomous or time-to-event efficacy endpoints summarized in Table 1 and each of Days 1 or 10 free-drug plasma %T >MIC and baseline MIC were evaluated. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2532. Pharmacokinetic-Pharmacodynamic Analyses for Ceftobiprole Efficacy Based on Phase 3 Data from Patients with Staphylococcus aureus Bacteremia
  16. 1043836
    por Anelli, M., Aoki, S., Arduini, G., Back, J.J., Bagulya, A., Baldini, W., Baranov, A., Barker, G.J., Barsuk, S., Battistin, M., Bauche, J., Bay, A., Bayliss, V., Bellagamba, L., Bencivenni, G., Bertani, M., Bezshyyko, O., Bick, D., Bingefors, N., Blondel, A., Bogomilov, M., Boyarsky, A., Bonacorsi, D., Bondarenko, D., Bonivento, W., Borburgh, J., Bradshaw, T., Brenner, R., Breton, D., Brook, N., Bruschi, M., Buonaura, A., Buontempo, S., Cadeddu, S., Calcaterra, A., Calviani, M., Campanelli, M., Capoccia, C., Cecchetti, A., Chatterjee, A., Chauveau, J., Chepurnov, A., Chernyavskiy, M., Ciambrone, P., Cicalo, C., Conti, G., Cornelis, K., Courthold, M., Dallavalle, M.G., D'Ambrosio, N., De Lellis, G., De Serio, M., Dedenko, L., Di Crescenzo, A., Di Marco, N., Dib, C., Dietrich, J., Dijkstra, H., Domenici, D., Donskov, S., Druzhkin, D., Ebert, J., Egede, U., Egorov, A., Egorychev, V., El Alaoui, M.A., Enik, T., Etenko, A., Fabbri, F., Fabbri, L., Fedorova, G., Felici, G., Ferro-Luzzi, M., Fini, R.A., Franke, M., Fraser, M., Galati, G., Giacobbe, B., Goddard, B., Golinka-Bezshyyko, L., Golubkov, D., Golutvin, A., Gorbunov, D., Graverini, E., Grenard, J-L, Guler, A.M., Hagner, C., Hakobyan, H., Helo, J.C., van Herwijnen, E., Horvath, D., Iacovacci, M., Iaselli, G., Jacobsson, R., Kadenko, I., Kamiscioglu, M., Kamiscioglu, C., Khaustov, G., Khotjansev, A., Kilminster, B., Kim, V., Kitagawa, N., Kodama, K., Kolesnikov, A., Kolev, D., Komatsu, M., Konovalova, N., Koretskiy, S., Korolko, I., Korzenev, A., Kovalenko, S., Kudenko, Y., Kuznetsova, E., Lacker, H., Lai, A., Lanfranchi, G., Lauria, A., Lebbolo, H., Levy, J.-M., Lista, L., Loverre, P., Lukiashin, A., Lyubovitskij, V.E., Malinin, A., Manfredi, M., Perillo-Marcone, A., Marrone, A., Matev, R., Messomo, E.N., Mermod, P., Mikado, S., Mikhaylov, Yu., Miller, J., Milstead, D., Mineev, O., Mingazheva, R., Mitselmakher, G., Miyanishi, M., Monacelli, P., Montanari, A., Montesi, M.C., Morello, G., Morishima, K., Movtchan, S., Murzin, V., Naganawa, N., Naka, T., Nakamura, M., Nakano, T., Nurakhov, N., Obinyakov, B., Ocalan, K., Ogawa, S., Oreshkin, V., Orlov, A., Osborne, J., Pacholek, P., Panman, J., Paoloni, A., Paparella, L., Pastore, A., Patel, M., Petridis, K., Petrushin, M., Poli-Lener, M., Polukhina, N., Polyakov, V., Prokudin, M., Puddu, G., Pupilli, F., Rademakers, F., Rakai, A., Rawlings, T., Redi, F., Ricciardi, S., Rinaldesi, R., Roganova, T., Rogozhnikov, A., Rokujo, H., Romaniouk, A., Rosa, G., Rostovtseva, I., Rovelli, T., Ruchayskiy, O., Ruf, T., Saitta, G., Samoylenko, V., Samsonov, V., Sanz Ull, A., Saputi, A., Sato, O., Schmidt-Parzefall, W., Serra, N., Sgobba, S., Shaposhnikov, M., Shatalov, P., Shaykhiev, A., Shchutska, L., Shevchenko, V., Shibuya, H., Shitov, Y., Silverstein, S., Simone, S., Skorokhvatov, M., Smirnov, S., Solodko, E., Sosnovtsev, V., Spighi, R., Spinetti, M., Starkov, N., Storaci, B., Strabel, C., Strolin, P., Takahashi, S., Teterin, P., Tioukov, V., Tommasini, D., Treille, D., Tsenov, R., Tshchedrina, T., Ustyuzhanin, A., Vannucci, F., Venturi, V., Villa, M., Vincke, Heinz, Vincke, Helmut, Vladymyrov, M., Xella, S., Yalvac, M., Yershov, N., Yilmaz, D., Yilmazer, A.U., Vankova-Kirilova, G., Zaitsev, Y., Zoccoli, A.
    Publicado 2015
    “…The robustness against various types of background is guaranteed by background taggers and a dedicated timing detector. The tau neutrino detector consists of an emulsion target equipped with tracking in a magnetic field followed by a muon spectrometer. …”
    Enlace del recurso
    A Facility to Search for Hidden Particles (SHiP) at the CERN SPS
  17. 1043837
    por Angelopoulos, V., Zhang, X.-J., Artemyev, A. V., Mourenas, D., Tsai, E., Wilkins, C., Runov, A., Liu, J., Turner, D. L., Li, W., Khurana, K., Wirz, R. E., Sergeev, V. A., Meng, X., Wu, J., Hartinger, M. D., Raita, T., Shen, Y., An, X., Shi, X., Bashir, M. F., Shen, X., Gan, L., Qin, M., Capannolo, L., Ma, Q., Russell, C. L., Masongsong, E. V., Caron, R., He, I., Iglesias, L., Jha, S., King, J., Kumar, S., Le, K., Mao, J., McDermott, A., Nguyen, K., Norris, A., Palla, A., Roosnovo, A., Tam, J., Xie, E., Yap, R. C., Ye, S., Young, C., Adair, L. A., Shaffer, C., Chung, M., Cruce, P., Lawson, M., Leneman, D., Allen, M., Anderson, M., Arreola-Zamora, M., Artinger, J., Asher, J., Branchevsky, D., Cliffe, M., Colton, K., Costello, C., Depe, D., Domae, B. W., Eldin, S., Fitzgibbon, L., Flemming, A., Frederick, D. M., Gilbert, A., Hesford, B., Krieger, R., Lian, K., McKinney, E., Miller, J. P., Pedersen, C., Qu, Z., Rozario, R., Rubly, M., Seaton, R., Subramanian, A., Sundin, S. R., Tan, A., Thomlinson, D., Turner, W., Wing, G., Wong, C., Zarifian, A.
    Publicado 2023
    “…Using multiple years of ELFIN data uniformly distributed in local time, we assemble a statistical database of ∼50 events of strong EMIC wave-driven precipitation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Energetic Electron Precipitation Driven by Electromagnetic Ion Cyclotron Waves from ELFIN’s Low Altitude Perspective
  18. 1043838
    “…In addition, the implementation is time-consuming and requires advanced programming skills and complex technical infrastructures. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The FeatureCloud Platform for Federated Learning in Biomedicine: Unified Approach
  19. 1043839
    “…These can be used as the basis for timely interventions to prevent relapse. However, there is considerable uncertainty regarding the implementation of EWS interventions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support
  20. 1043840
    por Murphy, Neil, Carreras-Torres, Robert, Song, Mingyang, Chan, Andrew T., Martin, Richard M., Papadimitriou, Nikos, Dimou, Niki, Tsilidis, Konstantinos K., Banbury, Barbara, Bradbury, Kathryn E., Besevic, Jelena, Rinaldi, Sabina, Riboli, Elio, Cross, Amanda J., Travis, Ruth C., Agnoli, Claudia, Albanes, Demetrius, Berndt, Sonja I., Bézieau, Stéphane, Bishop, D. Timothy, Brenner, Hermann, Buchanan, Daniel D., Onland-Moret, N. Charlotte, Burnett-Hartman, Andrea, Campbell, Peter T., Casey, Graham, Castellví-Bel, Sergi, Chang-Claude, Jenny, Chirlaque, María-Dolores, de la Chapelle, Albert, English, Dallas, Figueiredo, Jane C., Gallinger, Steven J., Giles, Graham G., Gruber, Stephen B., Gsur, Andrea, Hampe, Jochen, Hampel, Heather, Harrison, Tabitha A., Hoffmeister, Michael, Hsu, Li, Huang, Wen-Yi, Huyghe, Jeroen R., Jenkins, Mark A., Keku, Temitope O., Kühn, Tilman, Kweon, Sun-Seog, Le Marchand, Loic, Li, Christopher I., Li, Li, Lindblom, Annika, Martín, Vicente, Milne, Roger L., Moreno, Victor, Newcomb, Polly A., Offit, Kenneth, Ogino, Shuji, Ose, Jennifer, Perduca, Vittorio, Phipps, Amanda I., Platz, Elizabeth A., Potter, John D., Qu, Conghui, Rennert, Gad, Sakoda, Lori C., Schafmayer, Clemens, Schoen, Robert E., Slattery, Martha L., Tangen, Catherine M., Ulrich, Cornelia M., van Duijnhoven, Franzel J.B., Van Guelpen, Bethany, Visvanathan, Kala, Vodicka, Pavel, Vodickova, Ludmila, Vymetalkova, Veronika, Wang, Hansong, White, Emily, Wolk, Alicja, Woods, Michael O., Wu, Anna H., Zheng, Wei, Peters, Ulrike, Gunter, Marc J.
    Publicado 2020
    “…Similar associations were found by sex, follow-up time, and tumor subsite. In the MR analyses, a 1 standard deviation increment in IGF1 level, predicted based on genetic factors, was associated with a higher risk of colorectal cancer risk (odds ratio 1.08; 95% CI 1.03–1.12; P = 3.3 × 10(–4)). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses
Herramientas de búsqueda: RSS